| "Enterococcus" Thiercelin and Jouhaud 1903| Enterococcus| Enterococcus (ex Thiercelin and Jouhaud 1903) Schleifer and Kilpper-Balz 1984
Normal Microbiota: Enterococcus species are part of the normal microbial communities in the gastrointestinal tract of humans and animals. They contribute to the overall balance of the gut microbiota and play a role in various metabolic processes.
Infections: Some Enterococcus species, particularly Enterococcus faecalis and Enterococcus faecium, are known opportunistic pathogens. They can cause infections in various parts of the body, including urinary tract infections, bloodstream infections (bacteremia), and infective endocarditis. Enterococcal infections are often associated with healthcare settings, and certain strains may exhibit antibiotic resistance, posing challenges for treatment.
Antibiotic Resistance: Enterococcus species are notable for their ability to develop antibiotic resistance, including resistance to multiple drugs. This can complicate the treatment of infections caused by these bacteria, especially in healthcare settings where antibiotic-resistant strains may be prevalent.
Probiotic Potential: Despite the association with infections, certain strains of Enterococcus have been studied for their potential probiotic properties. Probiotics are live microorganisms that, when administered in adequate amounts, can confer health benefits to the host. Some Enterococcus strains may contribute to gastrointestinal health and immune modulation.
Other Sources for more information:
R2 | Slope | Tax Name | Parent Chart |
---|---|---|---|
0.3274410367012024 | 0.46285125613212585 | Peptoclostridium | Parent Taxa |
R2 | Slope | Tax Name | Parent Chart |
---|
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]